HOWL
Price
$0.92
Change
+$0.06 (+6.98%)
Updated
Dec 3 closing price
Capitalization
44.51M
105 days until earnings call
Intraday BUY SELL Signals
PHVS
Price
$29.36
Change
+$5.24 (+21.72%)
Updated
Dec 3 closing price
Capitalization
1.91B
131 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HOWL vs PHVS

Header iconHOWL vs PHVS Comparison
Open Charts HOWL vs PHVSBanner chart's image
Werewolf Therapeutics
Price$0.92
Change+$0.06 (+6.98%)
Volume$624.85K
Capitalization44.51M
Pharvaris
Price$29.36
Change+$5.24 (+21.72%)
Volume$3.54M
Capitalization1.91B
HOWL vs PHVS Comparison Chart in %
HOWL
Daily Signal:
Gain/Loss:
PHVS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
HOWL vs. PHVS commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOWL is a Hold and PHVS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (HOWL: $0.86 vs. PHVS: $24.18)
Brand notoriety: HOWL and PHVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HOWL: 45% vs. PHVS: 62%
Market capitalization -- HOWL: $44.51M vs. PHVS: $1.91B
HOWL [@Biotechnology] is valued at $44.51M. PHVS’s [@Biotechnology] market capitalization is $1.91B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOWL’s FA Score shows that 1 FA rating(s) are green whilePHVS’s FA Score has 0 green FA rating(s).

  • HOWL’s FA Score: 1 green, 4 red.
  • PHVS’s FA Score: 0 green, 5 red.
According to our system of comparison, PHVS is a better buy in the long-term than HOWL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOWL’s TA Score shows that 6 TA indicator(s) are bullish while PHVS’s TA Score has 6 bullish TA indicator(s).

  • HOWL’s TA Score: 6 bullish, 4 bearish.
  • PHVS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both HOWL and PHVS are a good buy in the short-term.

Price Growth

HOWL (@Biotechnology) experienced а -5.38% price change this week, while PHVS (@Biotechnology) price change was -4.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

HOWL is expected to report earnings on Mar 19, 2026.

PHVS is expected to report earnings on Apr 14, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHVS($1.91B) has a higher market cap than HOWL($44.5M). PHVS YTD gains are higher at: 26.135 vs. HOWL (-41.804). HOWL has higher annual earnings (EBITDA): -66.34M vs. PHVS (-165.21M). PHVS has more cash in the bank: 200M vs. HOWL (77.6M). PHVS has less debt than HOWL: PHVS (634K) vs HOWL (37.1M). HOWL (0) and PHVS (0) have equivalent revenues.
HOWLPHVSHOWL / PHVS
Capitalization44.5M1.91B2%
EBITDA-66.34M-165.21M40%
Gain YTD-41.80426.135-160%
P/E RatioN/AN/A-
Revenue00-
Total Cash77.6M200M39%
Total Debt37.1M634K5,852%
TECHNICAL ANALYSIS
Technical Analysis
HOWLPHVS
RSI
ODDS (%)
Bullish Trend 7 days ago
79%
Bearish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
81%
Bearish Trend 7 days ago
85%
Momentum
ODDS (%)
Bullish Trend 7 days ago
75%
Bullish Trend 7 days ago
84%
MACD
ODDS (%)
Bullish Trend 7 days ago
83%
Bullish Trend 7 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 7 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 7 days ago
82%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 7 days ago
77%
Declines
ODDS (%)
Bearish Trend 21 days ago
89%
Bearish Trend 21 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
78%
Bearish Trend 7 days ago
84%
Aroon
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 7 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
HOWL
Daily Signal:
Gain/Loss:
PHVS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSBPX32.42N/A
N/A
Principal SmallCap R5
GQETX37.44N/A
N/A
GMO Quality III
VLCGX18.23N/A
N/A
VALIC Company I Large Cap Core
EMAAX17.21N/A
N/A
Gabelli Entpr Mergers & Acquisitions A
MGOYX13.87N/A
N/A
Victory Mid-Cap Core Growth Y

HOWL and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOWL has been loosely correlated with CRBU. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if HOWL jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOWL
1D Price
Change %
HOWL100%
-6.05%
CRBU - HOWL
42%
Loosely correlated
-0.56%
IPSC - HOWL
41%
Loosely correlated
-2.62%
ALGS - HOWL
41%
Loosely correlated
+0.11%
CLDX - HOWL
40%
Loosely correlated
+2.85%
RXRX - HOWL
40%
Loosely correlated
-0.69%
More

PHVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHVS has been loosely correlated with INKT. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if PHVS jumps, then INKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHVS
1D Price
Change %
PHVS100%
-7.00%
INKT - PHVS
36%
Loosely correlated
-2.07%
NUVL - PHVS
34%
Loosely correlated
-1.37%
MGTX - PHVS
33%
Poorly correlated
-1.21%
HOWL - PHVS
31%
Poorly correlated
-6.05%
CELC - PHVS
30%
Poorly correlated
-1.01%
More